Attached files
file | filename |
---|---|
10-K - 10-K - AMAG PHARMACEUTICALS, INC. | a2196774z10-k.htm |
EX-31.1 - EXHIBIT 31.1 - AMAG PHARMACEUTICALS, INC. | a2196774zex-31_1.htm |
EX-32.1 - EXHIBIT 32.1 - AMAG PHARMACEUTICALS, INC. | a2196774zex-32_1.htm |
EX-31.2 - EXHIBIT 31.2 - AMAG PHARMACEUTICALS, INC. | a2196774zex-31_2.htm |
EX-10.2 - EXHIBIT 10.2 - AMAG PHARMACEUTICALS, INC. | a2196774zex-10_2.htm |
EX-23.1 - EXHIBIT 23.1 - AMAG PHARMACEUTICALS, INC. | a2196774zex-23_1.htm |
EX-21.1 - EXHIBIT 21.1 - AMAG PHARMACEUTICALS, INC. | a2196774zex-21_1.htm |
QuickLinks -- Click here to rapidly navigate through this document
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of AMAG Pharmaceuticals, Inc. (the "Company") on Form 10-K for the period ended December 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, David A. Arkowitz, Executive Vice President, Chief Financial Officer and Chief Business Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
- (1)
- The
Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
- (2)
- The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ DAVID A. ARKOWITZ David A. Arkowitz Executive Vice President, Chief Financial Officer and Chief Business Officer (principal financial and accounting officer) Dated: February 26, 2010 |